Samer Jaber Di Tommaso

Dr. Samer Jaber Di Tommaso

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2026 in Clinical Transplantation
Verified
Journal Article
Closed access
IGIgnacio Gondolesi
Ignacio Gondolesi
STSamer Jaber Di Tommaso
Samer Jaber Di Tommaso
RSRon Shapiro
Ron Shapiro
MPMichael A. Palese
Michael A. Palese

18 November 2025 in Complications
Verified
Journal Article
Open access
PDF file
LFLaura Karina Fumero
Laura Karina Fumero
Luis MedinaLuis Medina
Luis Medina
FEFederico Eskenazi
Federico Eskenazi
STSamer Jaber Di Tommaso
Samer Jaber Di Tommaso
AGAlvaro Gonzalo-Balbas
Alvaro Gonzalo-Balbas
Rene SoteloRene Sotelo
Rene Sotelo
Introduction: Rerouting urine flow is often required following radical cystectomy (RC). In this context, the ileal conduit (IC) has become the most common technique for urinary diversion, primarily due to its technical simplicity and suitability for patients with compromised renal function, elderly individuals, and those unable to perform self-catheterization. Objective: This review aims to highlight the complications of IC and categorize them into metabolic and surgical complications, further subdivided by timing (intraoperative, short-term, intermediate-term, and long-term) and anatomical location (uretero-ileal anastomosis, stoma, and ileal segment). Methods: A comprehensive narrative review was conducted to summarize the most common complications of IC, their clinical presentation, and management using Google Scholar, PubMed, and Embase databases to identify studies published from 1950 to 2024. Results: The morbidity associated with IC, especially when compared to continent diversions, remains a subject of debate. Notably, IC-related complications have been described with an incidence rate ranging from 39% to 67%. Conclusions: Providing a comprehensive overview of IC complications and management strategies can enhance clinical practice and improve patient outcomes.

19 October 2026 in Current Urology
Verified
Journal Article
Open access
IGIgnacio Gondolesi
Ignacio Gondolesi
STSamer Jaber Di Tommaso
Samer Jaber Di Tommaso
CCChih Peng Chin
Chih Peng Chin
FTFasika M. Tedla
Fasika M. Tedla
RSRon Shapiro
Ron Shapiro
MPMichael A. Palese
Michael A. Palese
Advances in renal transplantation have improved patient survival, but aging donor and recipient populations have increased the complexity of transplant care. Urologic malignancies and complications are increasingly important in this population: the reported risk of renal cell carcinoma is 2- to 10-fold higher and bladder cancer incidence is approximately 2- to 4-fold higher than in the general population. Urinary tract complications occur in 1% to 30% of recipients, highlighting the expanding role of urologists in transplant care. This comprehensive literature review summarizes the current role of urology in renal transplantation, focusing on the epidemiology and management of urologic malignancies relative to the general population, common posttransplant urologic complications and their management, and urologic strategies for expanding the donor pool. As the number and complexity of kidney transplant recipients continue to increase, transplant surgeons and general urologists need to understand these unique challenges. A multidisciplinary and individualized approach is essential to optimize outcomes, preserve graft function, and safely expand access to transplantation.

8 January 2026 in Cureus
Verified
Journal Article
Open access
PDF file
STSamer Jaber Di Tommaso
Samer Jaber Di Tommaso
RRRaul Riveros
Raul Riveros
RPRoberto Puente
Roberto Puente
MBMartin Bertacchi
Martin Bertacchi
FAFernando Abarzua
Fernando Abarzua
Background In Uruguay, prostate cancer is currently the most frequently diagnosed cancer in males and the second leading cause of cancer death. However, the mortality rate has been decreasing due to early diagnosis and treatment. Robotic surgery has played a very important role in the surgical treatment of prostate cancer, becoming the gold standard approach in different countries of the world. Only one robotic platform has been available in Uruguay since 2011. This study aimed to evaluate the perioperative, oncologic, and functional outcomes of the initial experience with robot-assisted radical prostatectomy in Uruguay, and to contextualize these results within internationally reported outcomes. Methodology This retrospective study analyzed outcomes of 70 patients who underwent radical robotic prostatectomy performed by a single surgeon during the initial phase of his robotic learning curve, defined as the first 70 consecutive cases performed under direct supervision by a certified proctor between March 2015 and December 2022. Results We report perioperative data, pathological findings, functional and oncological outcomes, and complications. The pathology report showed a 22.85% positive margin rate (11.11% of pT2 and 44% of pT3). The mean follow-up was 38 months. Complete continence was achieved in 93.54% of cases and potency in 66.12%. The conversion rate to open surgery was 1.42%, and Clavien grade III complications occurred in 4.2% of cases. Biochemical recurrence was observed in 19.35% of patients. Patients with positive margins and pT3 disease had significantly higher biochemical recurrence rates, and Kaplan-Meier analysis demonstrated a restricted mean biochemical recurrence-free survival of 50.7 months (95% confidence interval = 45.9-55.5). Conclusions Our functional and oncological outcomes and complication rates appear to be within the range reported in the international literature.

2 December 2025 in Urology Video Journal
Verified
Journal Article
Open access
LFLaura K Fumero
Laura K Fumero
STSamer Jaber Di Tommaso
Samer Jaber Di Tommaso
ÁGÁlvaro Gonzalo-Balbás
Álvaro Gonzalo-Balbás
FEFederico Eskenazi
Federico Eskenazi
RSRoberto Soto
Roberto Soto
RSRene Sotelo
Rene Sotelo